Tempus AI’s (TEM) Neutral Rating Reaffirmed at Piper Sandler

Piper Sandler reaffirmed their neutral rating on shares of Tempus AI (NASDAQ:TEM) in a research note issued to investors on Tuesday morning,Benzinga reports. The brokerage currently has a $70.00 target price on the stock, up from their previous target price of $40.00.

Other research analysts also recently issued reports about the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $47.00 price target on shares of Tempus AI in a research report on Wednesday, August 7th. Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and upped their target price for the company from $45.00 to $65.00 in a research note on Monday. Bank of America downgraded shares of Tempus AI from a “buy” rating to a “neutral” rating and boosted their price objective for the stock from $45.00 to $60.00 in a report on Wednesday, October 2nd. Loop Capital increased their target price on shares of Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research note on Tuesday, October 15th. Finally, JPMorgan Chase & Co. boosted their price target on Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, Tempus AI presently has a consensus rating of “Moderate Buy” and a consensus target price of $54.22.

Tempus AI Stock Performance

TEM stock opened at $68.04 on Tuesday. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 3.52. The company’s 50-day moving average price is $50.90. Tempus AI has a 52-week low of $22.89 and a 52-week high of $79.49.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. NEA Management Company LLC acquired a new position in shares of Tempus AI in the 2nd quarter worth approximately $160,048,000. Novo Holdings A S bought a new stake in Tempus AI during the 2nd quarter worth about $142,605,000. Revolution Growth Management Company Inc. acquired a new stake in Tempus AI in the 2nd quarter valued at about $128,133,000. ARK Investment Management LLC raised its stake in shares of Tempus AI by 355.0% in the third quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company’s stock worth $134,604,000 after acquiring an additional 1,855,459 shares during the last quarter. Finally, Alphabet Inc. acquired a new position in shares of Tempus AI during the second quarter worth approximately $54,289,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.